1. Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma. (1st March 2020) Authors: Vanbervliet-Defrance, Béatrice; Delaunay, Tiphaine; Daunizeau, Thomas; Kepenekian, Vahan; Glehen, Olivier; Weber, Kathrin; Estornes, Yann; Ziverec, Audrey; Djemal, Leila; Delphin, Marion; Lantuéjoul, Sylvie; Passot, Guillaume; Grégoire, Marc; Micheau, Olivier; Blanquart, Christophe; Renno, Toufic... Journal: Cancer letters Issue: Volume 472(2020) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy. Issue 9 (12th July 2022) Authors: Alcazer, Vincent; Bonaventura, Paola; Tonon, Laurie; Michel, Emilie; Mutez, Virginie; Fabres, Clémentine; Chuvin, Nicolas; Boulos, Rasha; Estornes, Yann; Maguer‐Satta, Véronique; Geistlich, Kevin; Viari, Alain; Metzeler, Klaus H.; Hiddemann, Wolfgang; Batch, Aarif M. N.; Herold, Tobias; Caux, Chr... Journal: American journal of hematology Issue: Volume 97:Issue 9(2022) Page Start: 1200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IAPs, regulators of innate immunity and inflammation. (March 2015) Authors: Estornes, Yann; Bertrand, Mathieu J.M. Journal: Seminars in cell & developmental biology Issue: Volume 39(2015) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapy. (August 2022) Authors: Mallet, Marion; Boulos, Rasha E.; Alcazer, Vincent; Bonaventura, Paola; Estornes, Yann; Chuvin, Nicolas; Depil, Stéphane Journal: European journal of cancer Issue: Volume 171(2022) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗